Filter
456
Text search:
antimalarial
drugs
Featured
Recommendations
54
New Publications
154
Language
Document type
No document type
256
Studies & Reports
71
Guidelines
57
Manuals
24
Training Material
16
Strategic & Response Plan
14
Fact sheets
9
Resource Platforms
4
Infographics
3
Situation Updates
2
Countries / Regions
Uganda
26
Global
26
India
24
Kenya
22
Sierra Leone
19
Liberia
18
Nigeria
17
Malawi
15
Zambia
14
Rwanda
14
Ghana
13
Tanzania
13
Ethiopia
12
Africa
11
Senegal
9
Latin America and the Carribbean
8
Nepal
6
Cambodia
6
Zimbabwe
5
Philippines
5
South Africa
5
Mozambique
5
South–East Asia Region
5
Cameroon
4
Thailand
4
Bangladesh
4
Vietnam
4
South Sudan
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
Asia
3
Laos
3
Burkina Faso
2
Somalia
2
Pakistan
2
China
2
Botswana
2
West and Central Africa
2
North America
2
Congo, Democratic Republic of
1
Mali
1
Lebanon
1
Chad
1
Indonesia
1
Namibia
1
Brazil
1
Libya
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Solomon Islands
1
Venezuela
1
Southern Africa
1
Timor Leste/ East Timor
1
Authors & Publishers
Publication Years
Category
Countries
255
Clinical Guidelines
46
Women & Child Health
29
Capacity Building
19
Public Health
19
Key Resources
13
Pharmacy & Technologies
12
Toolboxes
Malaria
76
Pharmacy
29
AMR
20
Ebola & Marburg
15
HIV
14
COVID-19
6
Caregiver
5
NTDs
5
Health Financing Toolbox
5
Rapid Response
4
2.0 Rapid Response
3
Polio
2
Conflict
2
Mental Health
2
Disability
1
Cholera
1
Natural Hazards
1
Zika
1
TB
1
Global Health Education
1
Planetary Health
1
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Meeting report, Kampala, Uganda,
7–8 November 2023
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries,
...
Revised Edition
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
Two test methods on dexamethasone tablets and injections
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care
...
WHO's Severe acute malnutrition with medical complications kit (SAM/MC) kit is a standard kit designed to provide medical treatment for 50 children under five suffering from severe malnutrition with medical complications. The SAM/MC kit includes antibiotics, antifungal, de-worming,
...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a
...